SEMAGLUTIDE

Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) analogue that plays a central role in glucose homeostasis. In research, it is extensively studied for its ability to enhance insulin release, reduce appetite, and support weight loss.

Key applications in scientific studies include:

• Modulating blood glucose levels in Type 2 diabetes models.

• Promoting satiety and reducing caloric intake, relevant in obesity and metabolic syndrome research.

• Enhancing insulin sensitivity, especially in insulin-resistant subjects.

• Cardiovascular and hepatic benefits, as shown in lipid profile and liver fat reduction studies.

Semaglutide’s extended half-life allows for once-weekly dosing in research, increasing consistency in longitudinal metabolic studies.

Reconstitution Instructions:

Reconstitute with BAC water. Refrigerate after reconstitution and use under sterile research conditions. Use our Peptide Calculator

For research purposes only. Not for human consumption.